We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEDP icon
3051
Medpace
MEDP
$16.5B
$4K ﹤0.01%
+74
New +$4.06K
MERC icon
3052
Mercer International
MERC
$39.8M
$4K ﹤0.01%
+337
New +$4.68K
METC icon
3053
Ramaco Resources Class A
METC
$649M
$4K ﹤0.01%
894
-609
-41% -$3.73K
MITK icon
3054
Mitek Systems
MITK
$834M
$4K ﹤0.01%
346
-9,610
-97% -$86.9K
MLKN icon
3055
MillerKnoll
MLKN
$1.67B
$4K ﹤0.01%
144
-7,776
-98% -$259K
MWA icon
3056
Mueller Water Products
MWA
$4.16B
$4K ﹤0.01%
+400
New +$4.19K
OFIX icon
3057
Orthofix Medical
OFIX
$419M
$4K ﹤0.01%
+76
New +$4.32K
PDLB icon
3058
Ponce Financial Group
PDLB
$485M
$4K ﹤0.01%
+413
New +$3.95K
PPLT
3059
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
$4K ﹤0.01%
570
QMCO icon
3060
Quantum Corp
QMCO
$474M
$4K ﹤0.01%
92
-256
-74% -$11.8K
RDFN
3061
DELISTED
Redfin
RDFN
$4K ﹤0.01%
+304
New +$4.83K
RGLS
3062
DELISTED
Regulus Therapeutics
RGLS
$4K ﹤0.01%
+434
New +$7.19K
RMI
3063
RiverNorth Opportunistic Municipal Income Fund
RMI
$101M
$4K ﹤0.01%
+200
New +$4.06K
SCPH
3064
DELISTED
scPharmaceuticals
SCPH
$4K ﹤0.01%
1,026
+751
+273% +$3.53K
SENS icon
3065
Senseonics Holdings Inc
SENS
$366M
$4K ﹤0.01%
+81
New +$5.41K
SFM icon
3066
Sprouts Farmers Market
SFM
$8.01B
$4K ﹤0.01%
187
-8,597
-98% -$224K
SGU icon
3067
Star Group
SGU
$423M
$4K ﹤0.01%
+440
New +$4.23K
SLAB icon
3068
Silicon Laboratories
SLAB
$7.23B
$4K ﹤0.01%
54
-2,604
-98% -$216K
SLNO
3069
DELISTED
Soleno Therapeutics
SLNO
$4K ﹤0.01%
+156
New +$4.55K
STNE icon
3070
StoneCo
STNE
$2.58B
$4K ﹤0.01%
+205
New +$4.74K
TILT icon
3071
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.26B
$4K ﹤0.01%
+42
New +$4.6K
UONEK icon
3072
Urban One Class D
UONEK
$23.8M
$4K ﹤0.01%
+221
New +$4.66K
UTSI icon
3073
UTStarcom
UTSI
$23.7M
$4K ﹤0.01%
358
+110
+44% +$1.52K
VIOT
3074
Viomi Technology
VIOT
$49.2M
$4K ﹤0.01%
+535
New +$4.54K
VRNA
3075
DELISTED
Verona Pharma
VRNA
$4K ﹤0.01%
442
+187
+73% +$2.12K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.